
|Articles|October 11, 2011
StudyManager Unveils Reveal Version 3.3
Advertisement
StudyManager
announced the release of
Reveal 3.3
, with enhanced features that provide greater ease of use and performance for research sites, academic medical centers, and hospitals.
Based on customer feedback and StudyManager’s nearly 20 years in the field, Reveal 3.3 offers a number of key ease-of-use and productivity enhancements, including:
- Study budget interface, enabling faster review of budgeted payables.
- A “Next Appointment” feature, which provides at-a-glance patient information, helping coordinators prepare for upcoming appointments.
- A capability allowing users to project and review patient visit “windows," helping to improve protocol compliance.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
2
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
3
ACT Brief: Neutral Tech Adoption at Sites, Scaling Unstructured Data for eSource, and Novo Nordisk’s CagriSema NDA
4
ACT Brief: Rethinking Site Support in 2026, GSK’s New Severe Asthma Approval, and Priority Review Momentum in Multiple Myeloma
5




